Skip to main
ZYNE
ZYNE logo

Zynerba Pharmaceuticals (ZYNE)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Zynerba Pharmaceuticals (ZYNE) Stock

About Zynerba Pharmaceuticals (ZYNE)

Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on the research and development of rare and near-rare neuropsychiatric conditions. The firm offers the Zygel product, which is formulated as a permeation-enhanced gel for transdermal delivery. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is hea...read more
Market cap$70.12M
Today's volume
Revenue (TTM)
Avg. daily volume1.03M
EBITDA (TTM)
Open
Price / earnings ratio-1.63x
Today's range
Debt / equity
52 week range$0.25 - $1.4
5 year debt / equity0.18x
Beta (LTM)0.83x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsAug 14, 2023
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 02, 2025, the market cap for ZYNE stock is $70.13M

The current P/E ratio for ZYNE stock is -1.63

The 52-week high for ZYNE stock is $1.40. The current ZYNE stock price $undefined is 100.00% below its 52-week high

The 52-week low for ZYNE stock is $0.25. The current ZYNE stock price $undefined has increased 100.00% from its 52-week low

No, the ZYNE stock does not pay dividends to its shareholders

How to buy ZYNE stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ZYNE stock

    Navigate to the Explore page. Then, type ZYNE into the search bar. When you see ZYNE stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ZYNE stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Zynerba Pharmaceuticals Stock Earnings

The value each ZYNE share was expected to gain vs. the value that each ZYNE share actually gained.

Zynerba Pharmaceuticals (ZYNE) reported Q2 2023 earnings per share (EPS) of -$0.21, missing estimates of -$0.20 by 5.00%. In the same quarter last year, Zynerba Pharmaceuticals's earnings per share (EPS) was -$0.24. Zynerba Pharmaceuticals is expected to release next earnings on 08/14/2023, with an earnings per share (EPS) estimate of $0.

Buy Zynerba Pharmaceuticals (ZYNE) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.